Literature DB >> 24038155

Estimating the loss in expectation of life due to cancer using flexible parametric survival models.

Therese M-L Andersson1, Paul W Dickman, Sandra Eloranta, Mats Lambe, Paul C Lambert.   

Abstract

A useful summary measure for survival data is the expectation of life, which is calculated by obtaining the area under a survival curve. The loss in expectation of life due to a certain type of cancer is the difference between the expectation of life in the general population and the expectation of life among the cancer patients. This measure is used little in practice as its estimation generally requires extrapolation of both the expected and observed survival. A parametric distribution can be used for extrapolation of the observed survival, but it is difficult to find a distribution that captures the underlying shape of the survival function after the end of follow-up. In this paper, we base our extrapolation on relative survival, because it is more stable and reliable. Relative survival is defined as the observed survival divided by the expected survival, and the mortality analogue is excess mortality. Approaches have been suggested for extrapolation of relative survival within life-table data, by assuming that the excess mortality has reached zero (statistical cure) or has stabilized to a constant. We propose the use of flexible parametric survival models for relative survival, which enables estimating the loss in expectation of life on individual level data by making these assumptions or by extrapolating the estimated linear trend at the end of follow-up. We have evaluated the extrapolation from this model using data on four types of cancer, and the results agree well with observed data.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; expectation of life; flexible parametric survival model; mean survival; population-based; relative survival

Mesh:

Year:  2013        PMID: 24038155     DOI: 10.1002/sim.5943

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  42 in total

1.  Estimating the impact of increasing cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program among low-income women in the USA.

Authors:  Lisa M Pollack; Donatus U Ekwueme; Mei-Chuan Hung; Jacqueline W Miller; Su-Hsin Chang
Journal:  Cancer Causes Control       Date:  2020-05-20       Impact factor: 2.506

2.  Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.

Authors:  Kun-Chia Chang; Jung-Der Wang; Andrew Saxon; Abigail G Matthews; George Woody; Yih-Ing Hser
Journal:  Int J Drug Policy       Date:  2017-02-01

3.  Reference-Adjusted Loss in Life Expectancy for Population-Based Cancer Patient Survival Comparisons-with an Application to Colon Cancer in Sweden.

Authors:  Therese M-L Andersson; Mark J Rutherford; Bjørn Møller; Paul C Lambert; Tor Åge Myklebust
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

4.  Burden of CKD and Cardiovascular Disease on Life Expectancy and Health Service Utilization: a Cohort Study of Hong Kong Chinese Hypertensive Patients.

Authors:  Eric Yuk Fai Wan; Esther Yee Tak Yu; Weng Yee Chin; Daniel Yee Tak Fong; Edmond Pui Hang Choi; Eric Ho Man Tang; Cindy Lo Kuen Lam
Journal:  J Am Soc Nephrol       Date:  2019-09-06       Impact factor: 10.121

5.  Single-Arm Phase II Survival Trial Design Under the Proportional Hazards Model.

Authors:  Jianrong Wu
Journal:  Stat Biopharm Res       Date:  2017-03-02       Impact factor: 1.452

6.  Estimating health benefits and cost-savings for achieving the Healthy People 2020 objective of reducing invasive colorectal cancer.

Authors:  Mei-Chuan Hung; Donatus U Ekwueme; Arica White; Sun Hee Rim; Jessica B King; Jung-Der Wang; Su-Hsin Chang
Journal:  Prev Med       Date:  2017-09-28       Impact factor: 4.018

7.  Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models.

Authors:  Coraline Danieli; Nadine Bossard; Laurent Roche; Aurelien Belot; Zoe Uhry; Hadrien Charvat; Laurent Remontet
Journal:  Biostatistics       Date:  2017-07-01       Impact factor: 5.899

8.  Mixture Cure Models in Oncology: A Tutorial and Practical Guidance.

Authors:  Federico Felizzi; Noman Paracha; Johannes Pöhlmann; Joshua Ray
Journal:  Pharmacoecon Open       Date:  2021-02-26

9.  Crude probability of death for cancer patients by spread of disease in New South Wales, Australia 1985 to 2014.

Authors:  Xue Qin Yu; Paramita Dasgupta; Clare Kahn; Kou Kou; Susanna Cramb; Peter Baade
Journal:  Cancer Med       Date:  2021-05-06       Impact factor: 4.452

10.  Association of healthy lifestyle score with all-cause mortality and life expectancy: a city-wide prospective cohort study of cancer survivors.

Authors:  Ce Sun; Ke Li; Huan Xu; Xiangjun Wang; Pengzhe Qin; Suixiang Wang; Boheng Liang; Lin Xu
Journal:  BMC Med       Date:  2021-07-07       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.